Efficacy and Safety of Purified Starch for Adhesion Prevention in Colorectal Surgery

Sponsor
Taipei Medical University Shuang Ho Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05580484
Collaborator
(none)
83
1
29.9
2.8

Study Details

Study Description

Brief Summary

Intra-abdominal adhesion occurs in up to 90% of patients after abdominal surgery. Many patient will undergo a second surgery for temporary stoma closure, therefore these ostomy closure operations can give an opportunity to evaluate adhesion caused by previous operations. This study was conducted to use second surgery to investigate the anti-adhesion effect of purified starch among patients who underwent colorectal surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Second surgery

Detailed Description

Data was analyzed from the medical records of patients who underwent a second surgery after colectomy between January 2020 and April 2022. Patient were allocated to either the purified starch group and control group. Since January 2020, adhesion scores have been registered in operation note when patients undergo a second colorectal surgery. The primary outcomes in this study were adhesion severity and adhesion area. The secondary outcomes were operation time, blood loss, and postopera-tive complications.

Study Design

Study Type:
Observational
Actual Enrollment :
83 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Efficacy and Safety of Purified Starch for Adhesion Prevention in Colorectal Surgery
Actual Study Start Date :
Jan 1, 2020
Actual Primary Completion Date :
May 1, 2022
Actual Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Purified starch/Control group

Patients who were willing to receive purified starch at their own expense during this first surgery were included in the purified starch group, and patients who did not re-ceive purified starch or other anti-adhesion products were included in the control group.

Procedure: Second surgery
The primary outcomes were adhesion severity and adhesion area in the lower ab-dominal cavity, as determined through direct visual observation of a laparotomy wound or laparoscopic observation from stoma closure wound.

Outcome Measures

Primary Outcome Measures

  1. Adhesion severity [three to six months]

    Adhesion severity was scored as grade 0 (no adhesion), grade I (filmy adhesion and blunt dissection), grade II (strong adhesion and sharp dissection), and grade III (very strong vascularized adhesion, sharp dissection, and damage barely preventable).

  2. Adhesion area [three to six months]

    Adhesion area was scored as grade 0 (no adhesion), grade I (adhesion of less than one-third of the area between the abdominal wall and the visceral organ in the lower abdominal cavity), grade II (adhesion of one-third and two-thirds of the area between the abdominal wall and the visceral organ in the lower abdominal cavity), and grade III (adhesion of more than two-thirds of the area between the abdominal wall and the visceral organ in the lower abdominal cavity).

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 100 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Patients who underwent a second surgery after colorectal resection between January 2020 and April 2022 were enrolled into this study.
Exclusion Criteria:
  • Patients who underwent a second surgery less than 1 month after the first colorectal resection or who developed peritoneum carcinomatosis in the second surgery and patients younger than 20 years were excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taipei Medical University Shuang-Ho Hospital New Taipei City Taiwan 235

Sponsors and Collaborators

  • Taipei Medical University Shuang Ho Hospital

Investigators

  • Study Chair: Tung-Cheng Chang, Taipei Medical University Shuang Ho Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tungcheng Chang, Chief of department of colorectal surgery, Taipei Medical University Shuang Ho Hospital
ClinicalTrials.gov Identifier:
NCT05580484
Other Study ID Numbers:
  • N202109018
First Posted:
Oct 14, 2022
Last Update Posted:
Oct 14, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2022